title: Telbivudine exhibits no inhibitory activity against HIV-1 clinical isolates in vitro.
authors.affiliation: Novartis Institutes for Biomedical Research, Inc., Cambridge, MA 02139, USA. kai.lin@novartis.com
authors.forename: Kai
authors.initials: K
authors.lastname: Lin
authors.forename: Sylwia
authors.initials: S
authors.lastname: Karwowska
authors.forename: Eric
authors.initials: E
authors.lastname: Lam
authors.forename: Kay
authors.initials: K
authors.lastname: Limoli
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Evans
authors.forename: Claudio
authors.initials: C
authors.lastname: Avila
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology; D000998:Antiviral Agents / Q000008:administration & dosage / Q000494:pharmacology*; D024882:Drug Resistance, Viral; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000821:virology; D015497:HIV-1 / Q000145:classification / Q000187:drug effects* / Q000302:isolation & purification; D006515:Hepatitis B virus / Q000187:drug effects; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy; D006801:Humans; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests; D009705:Nucleosides / Q000008:administration & dosage / Q000494:pharmacology*; D011744:Pyrimidinones / Q000008:administration & dosage / Q000494:pharmacology*; D000077712:Telbivudine; D013936:Thymidine / Q000031:analogs & derivatives
chemical_list: D019380:Anti-HIV Agents; D000998:Antiviral Agents; D009705:Nucleosides; D011744:Pyrimidinones; D000077712:Telbivudine; C413685:entecavir; D006147:Guanine; D013936:Thymidine